Federico Iovino

Title: Federico Iovino: Innovator in Vaccine Technology

Introduction

Federico Iovino is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of vaccine technology, particularly through his innovative work on microparticles derived from vaccine antigens. His research focuses on enhancing immunization methods, which can have a profound impact on public health.

Latest Patents

Iovino holds a patent for "Microparticles from vaccine antigens." This patent describes an isolated membrane vesicle microparticle (MP) that includes specific proteins at defined levels. The proteins mentioned in the patent include Ply, LytA, PspC, and RrgB, each with specified concentrations. These microparticles are designed for use in immunization and include methods for their manufacture.

Career Highlights

Federico Iovino is associated with Zalvac AB, a company focused on developing innovative vaccine solutions. His work at Zalvac AB has positioned him as a key player in the advancement of vaccine technology. With a patent portfolio that includes one significant patent, Iovino continues to push the boundaries of what is possible in immunization.

Collaborations

Iovino has collaborated with esteemed colleagues such as Birgitta Henriques Normark and Mario Codemo. These partnerships have fostered a collaborative environment that enhances the research and development of new vaccine technologies.

Conclusion

Federico Iovino's contributions to vaccine technology through his innovative patent and collaborations highlight his importance in the field. His work promises to advance immunization methods and improve public health outcomes.